HOME OUR TEAM TRANSACTIONS WHAT WE DO OUR APPROACH CONTACT Our team has advised on over: Includes transactions from previous firms 160 Life Science Transactions $ 15.6 Billion in M&A & Partnerships $ 5.3 Billion in Financings Select Transactions Sell Side $1,000,000,000+ Acquisition by Eli Lilly Acquisition by Danaher/IDT $1,360,000,000+ Acquisition by Eli Lilly $75,000,000+ Acquisition by Boston Scientific Private Placement & Strategic Advisory $114,000,000 Series D Preferred Stock $275,000,000 Series A Financing Strategic Advisor to Nuvation Bio $43,400,000 Series B Preferred Stock & Debt Partnering $2,000,000,000+ Partnership with Sanofi $252,000,000+ Ex-US Partnership with Santen $2,100,000,000 Partnership with AstraZeneca $765,000,000 Partnership with Astellas Buy Side $320,000,000 Acquisition of Zoladex in US, CAN from AstraZeneca $476,000,000 Acquisition of Performance Optics $335,000,000 Partnership with Curetech $337,500,000+ Purchase of SPL Transaction History $17,500,000 Series B Preferred Stock $1,000,000,000+ Acquisition by Eli Lilly Acquisition by Danaher/IDT $114,000,000 Series D Preferred Stock $1,500,000,000 Merger with Panacea — SPAC sponsored by EcoR1 Capital $45,000,000+ Global Partnership with Eisai Acquisition by Medtronic $1,360,000,000+ Acquisition by Eli Lilly $2,000,000,000+ Partnership with Sanofi $252,000,000+ Ex-US Partnership with Santen Acquisition by Exact Sciences Acquisition by Exact Sciences Acquisition by Becton Dickinson Acquisition by Altavant Services Strategic Investment and Partnership with IQVIA Global Partnership for Two Product Candidates $275,000,000 Series A Preferred Stock Merger with Oncternal Acquisition by undisclosed Global Life Sciences Company Acquisition by Private Equity-backed Pharma Company Investment + option to acquire by Global Medical Device company $56,400,000+ US Partnership for APADAZ with KVK $35,500,000 Acquisition by Ligand Spinout from Mt. Sinai Health Systems $2,100,000,000 Partnership with AstraZeneca Merger with Daré $250,000,000 Fairness Opinion on CTP-656 Acquisition by Vertex $320,000,000 Acquisition of Zoladex in US, CAN from AstraZeneca Merger with Capnia $476,000,000 Acquisition of Performance Optics $70,000,000 N. & S. America and Indian Partnership with Metchuen $150,000,000 Preferred Stock Acquisition by Becton Dickinson Acquisition by Midatech $75,000,000+ Acquisition by Boston Scientific Strategic Investment by Hanmi Acquisition of SPRIX from Luitpold $335,000,000 Partnership with Curetech $120,000,000 Acquisition by Nicox S.A. $43,400,000 Series B Preferred Stock & Debt $337,500,000+ Acquisition of SPL $40,000,000 Acquisition by Becton Dickinson $61,000,000 Africa, Middle East & CIS Partnership with Sanofi $25,000,000 Series C Preferred Stock $300,000,000 North American Partnership with Auxilium $250,000,000+ Acquisition by Actelion $100,000,000 European Partnership with Menarini $700,000,000 Acquisition by Pfizer $812,500,000 European Partnership with Baxter $50,000,000 Strategic Investment by Baxter Acquisition by Bionomics $207,500,000 Acquisition by Sanofi $22,500,000 Series B Preferred Stock $45,000,000 Series C Preferred Stock Acquisition of ROXRO PHARMA Acquisition by OriGene Acquisition of PharmaForce, Inc. Acquisition of Clarient $765,000,000 Partnership with Astellas Series B Preferred Stock $184,000,000 Acquisition by Roche Acquisition by Tethys Bioscience Acquisition by Thermo Fisher $26,500,000 Series C Preferred Stock $16,000,000 Series D Preferred Stock Acquisition by Ocimum $41,200,000 Series C Preferred Stock Acquisition by LabCorp $44,000,000 Series E Preferred Stock $31,000,000 Series C Preferred Stock $53,000,000 Series B Preferred Stock & Debt $60,000,000 Series C Preferred Stock $85,000,000 Series B Preferred Stock & Debt Acquisition by Genetix Acquisition by Nektar Acquisition by Invitrogen Acquisition by Fisher Scientific $62,500,000 Series D Preferred Stock Acquisition by Agilent Technologies $65,000,000 Series C Preferred Stock Member FINRA / SIPC LOCATIONS San Francisco 601 California Street, 5th Floor San Francisco, CA 94108 (415) 677-9773 info@aquilopartners.com New York 888 Seventh Avenue, 12th Floor New York, NY 10106 (415) 505-2748 info@aquilopartners.com Boston 101 Main Street, 14th Floor Cambridge, MA 02142 (617) 401-2483 info@aquilopartners.com CONTACT US (415) 677-9773 info@aquilopartners.com SITE MAP Home Our Team Transactions What We Do Our Approach Disclosure Contact Aquilo Partners, L.P. © 2001-2020. All Rights Reserved.